A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Molluscum Contagiosum
Phase of Trial: Phase II
Latest Information Update: 16 Oct 2018
Price : $35 *
At a glance
- Drugs Povidone iodine (Primary)
- Indications Molluscum contagiosum
- Focus Therapeutic Use
- Sponsors Veloce BioPharma
- 09 Oct 2018 Status changed from active, no longer recruiting to completed.
- 31 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2018.
- 31 Jan 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2018.